tiprankstipranks
Tempest Therapeutics (TPST)
NASDAQ:TPST
US Market
TPST
Tempest Therapeutics
RESEARCH TOOLSreports
Want to see TPST full AI Analyst Report?

Tempest Therapeutics (TPST) Income Statement

1,267 Followers

Tempest Therapeutics Income Statement

Last quarter (Q4 2025), Tempest Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tempest Therapeutics's net income was $-4.02M. See Tempest Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -389.00K$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 26.57M$ 41.64M$ 29.16M$ 34.64M$ 26.99M
Depreciation and Amortization
$ 266.00K$ 389.00K$ 381.00K$ 638.00K$ 374.00K
EBITDA
$ -25.79M$ -40.14M$ -27.66M$ -33.45M$ -26.65M
Operating Income
$ -26.57M$ -42.03M$ -29.16M$ -34.64M$ -26.99M
Other Income/Expenses
$ 313.00K$ 183.00K$ -334.00K$ -1.07M$ -1.32M
Pretax Income
$ -26.26M$ -41.84M$ -29.49M$ -35.71M$ -28.30M
Net Income
$ -26.26M$ -41.84M$ -29.49M$ -35.71M$ -28.30M
Per Share Metrics
Basic EPS
$ -6.33$ -1.50$ -1.91$ -3.18$ -7.80
Diluted EPS
$ -6.33$ -1.50$ -1.91$ -3.18$ -7.80
Weighted Average Shares Outstanding
 4.15M 27.90M 15.42M 888.00K 291.00K
Weighted Average Shares Outstanding (Diluted)
 4.15M 27.90M 15.42M 888.38K 291.56K
Currency in USD

Tempest Therapeutics Earnings and Revenue History